BIOCHEM BIOPH RES CO 润色咨询

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

出版年份:1959 年文章数:31561 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:4.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1001755, encodeId=ac031001e55a5, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:请问BBRC杂志社再哪里,和中国的时差是多少?有朋友知道吗<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60f35540575, createdName=Dr.静, createdTime=Thu Jul 22 18:03:28 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2292649, encodeId=08822292649e2, content=2025年12月9日 投稿,7800多号,求接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Dec 10 11:21:15 CST 2025, time=2025-12-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2276798, encodeId=246e22e6798e8, content=2025年8月10日投稿,上传了3次WB原图裁剪过的,现在状态是SBJ,被接受了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac279471506, createdName=ms2000001739517612, createdTime=Mon Aug 11 12:23:53 CST 2025, time=2025-08-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向:microRNA<br>经验分享:修回后with editor已经2周了。。。会不会被拒啊??现在到几号投稿了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0<br>经验分享:1.18投稿,2周后写了催稿信,2.11退回,要求润色并上传WB原图,2.18号重新提交,(附了邮件说明),2.22 under review,2.24接收。很不好意思中间写了两次催稿信,但是真的心急如焚,很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275749, encodeId=225922e57497b, content=7月21号从同门那里听说了BBRC这个神刊,2周左右要么直接接收要么拒稿,前面已经被拒了很多个杂志了,听到这个杂志我就很心动,因为着急要一篇文章保命,我马上着手准备稿件,投的short communication,要求包含所有内容4600字以内,4个figure,花了两天时间改好稿件,23号早上投过去,24号晚上就收到了编辑的拒稿信,写了6点需要重大修改的地方,我当时都觉得没什么希望了,转头去搞另一篇文章去了,后面又回过头来对着意见逐条修改回复,终于又在29号早上重新提交回去了,31号凌晨2点多收到了拒稿小修的邮件,早上起来马上改了又重新提交,当天晚上11点就收到了接收的邮件。现在在写这个经验分享的时候就收到了杂志的校稿邮件,这个杂志简直是保命神刊,效率超高,有需要的小伙伴闭眼冲。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79ae5715706, createdName=ms2000000094539848, createdTime=Sat Aug 02 10:07:46 CST 2025, time=2025-08-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志现在是真的慢,投稿10天了是一点反馈都没有!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=663, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿,杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省)]
    2021-07-22 Dr.静

    偏重的研究方向:分子生物学;肿瘤
    经验分享:请问BBRC杂志社再哪里,和中国的时差是多少?有朋友知道吗#梅斯医学科研互助群#

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1001755, encodeId=ac031001e55a5, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:请问BBRC杂志社再哪里,和中国的时差是多少?有朋友知道吗<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60f35540575, createdName=Dr.静, createdTime=Thu Jul 22 18:03:28 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2292649, encodeId=08822292649e2, content=2025年12月9日 投稿,7800多号,求接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Dec 10 11:21:15 CST 2025, time=2025-12-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2276798, encodeId=246e22e6798e8, content=2025年8月10日投稿,上传了3次WB原图裁剪过的,现在状态是SBJ,被接受了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac279471506, createdName=ms2000001739517612, createdTime=Mon Aug 11 12:23:53 CST 2025, time=2025-08-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向:microRNA<br>经验分享:修回后with editor已经2周了。。。会不会被拒啊??现在到几号投稿了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0<br>经验分享:1.18投稿,2周后写了催稿信,2.11退回,要求润色并上传WB原图,2.18号重新提交,(附了邮件说明),2.22 under review,2.24接收。很不好意思中间写了两次催稿信,但是真的心急如焚,很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275749, encodeId=225922e57497b, content=7月21号从同门那里听说了BBRC这个神刊,2周左右要么直接接收要么拒稿,前面已经被拒了很多个杂志了,听到这个杂志我就很心动,因为着急要一篇文章保命,我马上着手准备稿件,投的short communication,要求包含所有内容4600字以内,4个figure,花了两天时间改好稿件,23号早上投过去,24号晚上就收到了编辑的拒稿信,写了6点需要重大修改的地方,我当时都觉得没什么希望了,转头去搞另一篇文章去了,后面又回过头来对着意见逐条修改回复,终于又在29号早上重新提交回去了,31号凌晨2点多收到了拒稿小修的邮件,早上起来马上改了又重新提交,当天晚上11点就收到了接收的邮件。现在在写这个经验分享的时候就收到了杂志的校稿邮件,这个杂志简直是保命神刊,效率超高,有需要的小伙伴闭眼冲。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79ae5715706, createdName=ms2000000094539848, createdTime=Sat Aug 02 10:07:46 CST 2025, time=2025-08-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志现在是真的慢,投稿10天了是一点反馈都没有!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=663, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿,杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省)]
    2025-12-10 laal 来自北京

    2025年12月9日 投稿,7800多号,求接收

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1001755, encodeId=ac031001e55a5, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:请问BBRC杂志社再哪里,和中国的时差是多少?有朋友知道吗<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60f35540575, createdName=Dr.静, createdTime=Thu Jul 22 18:03:28 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2292649, encodeId=08822292649e2, content=2025年12月9日 投稿,7800多号,求接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Dec 10 11:21:15 CST 2025, time=2025-12-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2276798, encodeId=246e22e6798e8, content=2025年8月10日投稿,上传了3次WB原图裁剪过的,现在状态是SBJ,被接受了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac279471506, createdName=ms2000001739517612, createdTime=Mon Aug 11 12:23:53 CST 2025, time=2025-08-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向:microRNA<br>经验分享:修回后with editor已经2周了。。。会不会被拒啊??现在到几号投稿了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0<br>经验分享:1.18投稿,2周后写了催稿信,2.11退回,要求润色并上传WB原图,2.18号重新提交,(附了邮件说明),2.22 under review,2.24接收。很不好意思中间写了两次催稿信,但是真的心急如焚,很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275749, encodeId=225922e57497b, content=7月21号从同门那里听说了BBRC这个神刊,2周左右要么直接接收要么拒稿,前面已经被拒了很多个杂志了,听到这个杂志我就很心动,因为着急要一篇文章保命,我马上着手准备稿件,投的short communication,要求包含所有内容4600字以内,4个figure,花了两天时间改好稿件,23号早上投过去,24号晚上就收到了编辑的拒稿信,写了6点需要重大修改的地方,我当时都觉得没什么希望了,转头去搞另一篇文章去了,后面又回过头来对着意见逐条修改回复,终于又在29号早上重新提交回去了,31号凌晨2点多收到了拒稿小修的邮件,早上起来马上改了又重新提交,当天晚上11点就收到了接收的邮件。现在在写这个经验分享的时候就收到了杂志的校稿邮件,这个杂志简直是保命神刊,效率超高,有需要的小伙伴闭眼冲。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79ae5715706, createdName=ms2000000094539848, createdTime=Sat Aug 02 10:07:46 CST 2025, time=2025-08-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志现在是真的慢,投稿10天了是一点反馈都没有!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=663, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿,杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省)]
    2025-08-11 ms2000001739517612 来自山东省

    2025年8月10日投稿,上传了3次WB原图裁剪过的,现在状态是SBJ,被接受了来还愿

    11

    展开11条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1001755, encodeId=ac031001e55a5, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:请问BBRC杂志社再哪里,和中国的时差是多少?有朋友知道吗<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60f35540575, createdName=Dr.静, createdTime=Thu Jul 22 18:03:28 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2292649, encodeId=08822292649e2, content=2025年12月9日 投稿,7800多号,求接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Dec 10 11:21:15 CST 2025, time=2025-12-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2276798, encodeId=246e22e6798e8, content=2025年8月10日投稿,上传了3次WB原图裁剪过的,现在状态是SBJ,被接受了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac279471506, createdName=ms2000001739517612, createdTime=Mon Aug 11 12:23:53 CST 2025, time=2025-08-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向:microRNA<br>经验分享:修回后with editor已经2周了。。。会不会被拒啊??现在到几号投稿了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0<br>经验分享:1.18投稿,2周后写了催稿信,2.11退回,要求润色并上传WB原图,2.18号重新提交,(附了邮件说明),2.22 under review,2.24接收。很不好意思中间写了两次催稿信,但是真的心急如焚,很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275749, encodeId=225922e57497b, content=7月21号从同门那里听说了BBRC这个神刊,2周左右要么直接接收要么拒稿,前面已经被拒了很多个杂志了,听到这个杂志我就很心动,因为着急要一篇文章保命,我马上着手准备稿件,投的short communication,要求包含所有内容4600字以内,4个figure,花了两天时间改好稿件,23号早上投过去,24号晚上就收到了编辑的拒稿信,写了6点需要重大修改的地方,我当时都觉得没什么希望了,转头去搞另一篇文章去了,后面又回过头来对着意见逐条修改回复,终于又在29号早上重新提交回去了,31号凌晨2点多收到了拒稿小修的邮件,早上起来马上改了又重新提交,当天晚上11点就收到了接收的邮件。现在在写这个经验分享的时候就收到了杂志的校稿邮件,这个杂志简直是保命神刊,效率超高,有需要的小伙伴闭眼冲。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79ae5715706, createdName=ms2000000094539848, createdTime=Sat Aug 02 10:07:46 CST 2025, time=2025-08-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志现在是真的慢,投稿10天了是一点反馈都没有!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=663, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿,杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省)]
    2025-06-22 ms6000002121995865 来自北京

    偏重的研究方向:microRNA
    经验分享:修回后with editor已经2周了。。。会不会被拒啊??现在到几号投稿了?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1001755, encodeId=ac031001e55a5, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:请问BBRC杂志社再哪里,和中国的时差是多少?有朋友知道吗<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60f35540575, createdName=Dr.静, createdTime=Thu Jul 22 18:03:28 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2292649, encodeId=08822292649e2, content=2025年12月9日 投稿,7800多号,求接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Dec 10 11:21:15 CST 2025, time=2025-12-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2276798, encodeId=246e22e6798e8, content=2025年8月10日投稿,上传了3次WB原图裁剪过的,现在状态是SBJ,被接受了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac279471506, createdName=ms2000001739517612, createdTime=Mon Aug 11 12:23:53 CST 2025, time=2025-08-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向:microRNA<br>经验分享:修回后with editor已经2周了。。。会不会被拒啊??现在到几号投稿了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0<br>经验分享:1.18投稿,2周后写了催稿信,2.11退回,要求润色并上传WB原图,2.18号重新提交,(附了邮件说明),2.22 under review,2.24接收。很不好意思中间写了两次催稿信,但是真的心急如焚,很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275749, encodeId=225922e57497b, content=7月21号从同门那里听说了BBRC这个神刊,2周左右要么直接接收要么拒稿,前面已经被拒了很多个杂志了,听到这个杂志我就很心动,因为着急要一篇文章保命,我马上着手准备稿件,投的short communication,要求包含所有内容4600字以内,4个figure,花了两天时间改好稿件,23号早上投过去,24号晚上就收到了编辑的拒稿信,写了6点需要重大修改的地方,我当时都觉得没什么希望了,转头去搞另一篇文章去了,后面又回过头来对着意见逐条修改回复,终于又在29号早上重新提交回去了,31号凌晨2点多收到了拒稿小修的邮件,早上起来马上改了又重新提交,当天晚上11点就收到了接收的邮件。现在在写这个经验分享的时候就收到了杂志的校稿邮件,这个杂志简直是保命神刊,效率超高,有需要的小伙伴闭眼冲。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79ae5715706, createdName=ms2000000094539848, createdTime=Sat Aug 02 10:07:46 CST 2025, time=2025-08-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志现在是真的慢,投稿10天了是一点反馈都没有!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=663, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿,杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省)]
    2021-02-25 ms2205852206988122

    审稿速度:1.0
    经验分享:1.18投稿,2周后写了催稿信,2.11退回,要求润色并上传WB原图,2.18号重新提交,(附了邮件说明),2.22 under review,2.24接收。很不好意思中间写了两次催稿信,但是真的心急如焚,很难熬。希望大家都可以收到好消息。

    29

    展开29条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1001755, encodeId=ac031001e55a5, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:请问BBRC杂志社再哪里,和中国的时差是多少?有朋友知道吗<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60f35540575, createdName=Dr.静, createdTime=Thu Jul 22 18:03:28 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2292649, encodeId=08822292649e2, content=2025年12月9日 投稿,7800多号,求接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Dec 10 11:21:15 CST 2025, time=2025-12-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2276798, encodeId=246e22e6798e8, content=2025年8月10日投稿,上传了3次WB原图裁剪过的,现在状态是SBJ,被接受了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac279471506, createdName=ms2000001739517612, createdTime=Mon Aug 11 12:23:53 CST 2025, time=2025-08-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向:microRNA<br>经验分享:修回后with editor已经2周了。。。会不会被拒啊??现在到几号投稿了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0<br>经验分享:1.18投稿,2周后写了催稿信,2.11退回,要求润色并上传WB原图,2.18号重新提交,(附了邮件说明),2.22 under review,2.24接收。很不好意思中间写了两次催稿信,但是真的心急如焚,很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275749, encodeId=225922e57497b, content=7月21号从同门那里听说了BBRC这个神刊,2周左右要么直接接收要么拒稿,前面已经被拒了很多个杂志了,听到这个杂志我就很心动,因为着急要一篇文章保命,我马上着手准备稿件,投的short communication,要求包含所有内容4600字以内,4个figure,花了两天时间改好稿件,23号早上投过去,24号晚上就收到了编辑的拒稿信,写了6点需要重大修改的地方,我当时都觉得没什么希望了,转头去搞另一篇文章去了,后面又回过头来对着意见逐条修改回复,终于又在29号早上重新提交回去了,31号凌晨2点多收到了拒稿小修的邮件,早上起来马上改了又重新提交,当天晚上11点就收到了接收的邮件。现在在写这个经验分享的时候就收到了杂志的校稿邮件,这个杂志简直是保命神刊,效率超高,有需要的小伙伴闭眼冲。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79ae5715706, createdName=ms2000000094539848, createdTime=Sat Aug 02 10:07:46 CST 2025, time=2025-08-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志现在是真的慢,投稿10天了是一点反馈都没有!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=663, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿,杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省)]
    2025-08-02 ms2000000094539848 来自四川省

    7月21号从同门那里听说了BBRC这个神刊,2周左右要么直接接收要么拒稿,前面已经被拒了很多个杂志了,听到这个杂志我就很心动,因为着急要一篇文章保命,我马上着手准备稿件,投的short communication,要求包含所有内容4600字以内,4个figure,花了两天时间改好稿件,23号早上投过去,24号晚上就收到了编辑的拒稿信,写了6点需要重大修改的地方,我当时都觉得没什么希望了,转头去搞另一篇文章去了,后面又回过头来对着意见逐条修改回复,终于又在29号早上重新提交回去了,31号凌晨2点多收到了拒稿小修的邮件,早上起来马上改了又重新提交,当天晚上11点就收到了接收的邮件。现在在写这个经验分享的时候就收到了杂志的校稿邮件,这个杂志简直是保命神刊,效率超高,有需要的小伙伴闭眼冲。。。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1001755, encodeId=ac031001e55a5, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:请问BBRC杂志社再哪里,和中国的时差是多少?有朋友知道吗<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60f35540575, createdName=Dr.静, createdTime=Thu Jul 22 18:03:28 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2292649, encodeId=08822292649e2, content=2025年12月9日 投稿,7800多号,求接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Dec 10 11:21:15 CST 2025, time=2025-12-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2276798, encodeId=246e22e6798e8, content=2025年8月10日投稿,上传了3次WB原图裁剪过的,现在状态是SBJ,被接受了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac279471506, createdName=ms2000001739517612, createdTime=Mon Aug 11 12:23:53 CST 2025, time=2025-08-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向:microRNA<br>经验分享:修回后with editor已经2周了。。。会不会被拒啊??现在到几号投稿了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0<br>经验分享:1.18投稿,2周后写了催稿信,2.11退回,要求润色并上传WB原图,2.18号重新提交,(附了邮件说明),2.22 under review,2.24接收。很不好意思中间写了两次催稿信,但是真的心急如焚,很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275749, encodeId=225922e57497b, content=7月21号从同门那里听说了BBRC这个神刊,2周左右要么直接接收要么拒稿,前面已经被拒了很多个杂志了,听到这个杂志我就很心动,因为着急要一篇文章保命,我马上着手准备稿件,投的short communication,要求包含所有内容4600字以内,4个figure,花了两天时间改好稿件,23号早上投过去,24号晚上就收到了编辑的拒稿信,写了6点需要重大修改的地方,我当时都觉得没什么希望了,转头去搞另一篇文章去了,后面又回过头来对着意见逐条修改回复,终于又在29号早上重新提交回去了,31号凌晨2点多收到了拒稿小修的邮件,早上起来马上改了又重新提交,当天晚上11点就收到了接收的邮件。现在在写这个经验分享的时候就收到了杂志的校稿邮件,这个杂志简直是保命神刊,效率超高,有需要的小伙伴闭眼冲。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79ae5715706, createdName=ms2000000094539848, createdTime=Sat Aug 02 10:07:46 CST 2025, time=2025-08-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志现在是真的慢,投稿10天了是一点反馈都没有!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=663, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿,杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省)]
    2020-07-23 17142086d7m

    审稿速度:1.0 | 投稿命中率:100.0
    偏重的研究方向:神经生物学;细胞生物学;分子生物学
    经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!

    57

    展开57条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1001755, encodeId=ac031001e55a5, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:请问BBRC杂志社再哪里,和中国的时差是多少?有朋友知道吗<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60f35540575, createdName=Dr.静, createdTime=Thu Jul 22 18:03:28 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2292649, encodeId=08822292649e2, content=2025年12月9日 投稿,7800多号,求接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Dec 10 11:21:15 CST 2025, time=2025-12-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2276798, encodeId=246e22e6798e8, content=2025年8月10日投稿,上传了3次WB原图裁剪过的,现在状态是SBJ,被接受了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac279471506, createdName=ms2000001739517612, createdTime=Mon Aug 11 12:23:53 CST 2025, time=2025-08-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向:microRNA<br>经验分享:修回后with editor已经2周了。。。会不会被拒啊??现在到几号投稿了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0<br>经验分享:1.18投稿,2周后写了催稿信,2.11退回,要求润色并上传WB原图,2.18号重新提交,(附了邮件说明),2.22 under review,2.24接收。很不好意思中间写了两次催稿信,但是真的心急如焚,很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275749, encodeId=225922e57497b, content=7月21号从同门那里听说了BBRC这个神刊,2周左右要么直接接收要么拒稿,前面已经被拒了很多个杂志了,听到这个杂志我就很心动,因为着急要一篇文章保命,我马上着手准备稿件,投的short communication,要求包含所有内容4600字以内,4个figure,花了两天时间改好稿件,23号早上投过去,24号晚上就收到了编辑的拒稿信,写了6点需要重大修改的地方,我当时都觉得没什么希望了,转头去搞另一篇文章去了,后面又回过头来对着意见逐条修改回复,终于又在29号早上重新提交回去了,31号凌晨2点多收到了拒稿小修的邮件,早上起来马上改了又重新提交,当天晚上11点就收到了接收的邮件。现在在写这个经验分享的时候就收到了杂志的校稿邮件,这个杂志简直是保命神刊,效率超高,有需要的小伙伴闭眼冲。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79ae5715706, createdName=ms2000000094539848, createdTime=Sat Aug 02 10:07:46 CST 2025, time=2025-08-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志现在是真的慢,投稿10天了是一点反馈都没有!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=663, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿,杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省)]
    2025-05-09 ms5000000138196922 来自上海

    请问那个short com有啥区别嘛?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1001755, encodeId=ac031001e55a5, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:请问BBRC杂志社再哪里,和中国的时差是多少?有朋友知道吗<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60f35540575, createdName=Dr.静, createdTime=Thu Jul 22 18:03:28 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2292649, encodeId=08822292649e2, content=2025年12月9日 投稿,7800多号,求接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Dec 10 11:21:15 CST 2025, time=2025-12-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2276798, encodeId=246e22e6798e8, content=2025年8月10日投稿,上传了3次WB原图裁剪过的,现在状态是SBJ,被接受了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac279471506, createdName=ms2000001739517612, createdTime=Mon Aug 11 12:23:53 CST 2025, time=2025-08-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向:microRNA<br>经验分享:修回后with editor已经2周了。。。会不会被拒啊??现在到几号投稿了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0<br>经验分享:1.18投稿,2周后写了催稿信,2.11退回,要求润色并上传WB原图,2.18号重新提交,(附了邮件说明),2.22 under review,2.24接收。很不好意思中间写了两次催稿信,但是真的心急如焚,很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275749, encodeId=225922e57497b, content=7月21号从同门那里听说了BBRC这个神刊,2周左右要么直接接收要么拒稿,前面已经被拒了很多个杂志了,听到这个杂志我就很心动,因为着急要一篇文章保命,我马上着手准备稿件,投的short communication,要求包含所有内容4600字以内,4个figure,花了两天时间改好稿件,23号早上投过去,24号晚上就收到了编辑的拒稿信,写了6点需要重大修改的地方,我当时都觉得没什么希望了,转头去搞另一篇文章去了,后面又回过头来对着意见逐条修改回复,终于又在29号早上重新提交回去了,31号凌晨2点多收到了拒稿小修的邮件,早上起来马上改了又重新提交,当天晚上11点就收到了接收的邮件。现在在写这个经验分享的时候就收到了杂志的校稿邮件,这个杂志简直是保命神刊,效率超高,有需要的小伙伴闭眼冲。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79ae5715706, createdName=ms2000000094539848, createdTime=Sat Aug 02 10:07:46 CST 2025, time=2025-08-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志现在是真的慢,投稿10天了是一点反馈都没有!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=663, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿,杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省)]
    2024-07-22 biocell160 来自贵州省

    偏重的研究方向:肿瘤
    经验分享:这个杂志现在是真的慢,投稿10天了是一点反馈都没有!

    9

    展开9条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1001755, encodeId=ac031001e55a5, content=偏重的研究方向:分子生物学;肿瘤<br>经验分享:请问BBRC杂志社再哪里,和中国的时差是多少?有朋友知道吗<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60f35540575, createdName=Dr.静, createdTime=Thu Jul 22 18:03:28 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2292649, encodeId=08822292649e2, content=2025年12月9日 投稿,7800多号,求接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Dec 10 11:21:15 CST 2025, time=2025-12-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2276798, encodeId=246e22e6798e8, content=2025年8月10日投稿,上传了3次WB原图裁剪过的,现在状态是SBJ,被接受了来还愿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac279471506, createdName=ms2000001739517612, createdTime=Mon Aug 11 12:23:53 CST 2025, time=2025-08-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2270348, encodeId=466322e034803, content=偏重的研究方向:microRNA<br>经验分享:修回后with editor已经2周了。。。会不会被拒啊??现在到几号投稿了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85a8179531, createdName=ms6000002121995865, createdTime=Sun Jun 22 00:20:42 CST 2025, time=2025-06-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=927061, encodeId=853092e061b8, content=审稿速度:1.0<br>经验分享:1.18投稿,2周后写了催稿信,2.11退回,要求润色并上传WB原图,2.18号重新提交,(附了邮件说明),2.22 under review,2.24接收。很不好意思中间写了两次催稿信,但是真的心急如焚,很难熬。希望大家都可以收到好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Thu Feb 25 11:10:37 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2275749, encodeId=225922e57497b, content=7月21号从同门那里听说了BBRC这个神刊,2周左右要么直接接收要么拒稿,前面已经被拒了很多个杂志了,听到这个杂志我就很心动,因为着急要一篇文章保命,我马上着手准备稿件,投的short communication,要求包含所有内容4600字以内,4个figure,花了两天时间改好稿件,23号早上投过去,24号晚上就收到了编辑的拒稿信,写了6点需要重大修改的地方,我当时都觉得没什么希望了,转头去搞另一篇文章去了,后面又回过头来对着意见逐条修改回复,终于又在29号早上重新提交回去了,31号凌晨2点多收到了拒稿小修的邮件,早上起来马上改了又重新提交,当天晚上11点就收到了接收的邮件。现在在写这个经验分享的时候就收到了杂志的校稿邮件,这个杂志简直是保命神刊,效率超高,有需要的小伙伴闭眼冲。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79ae5715706, createdName=ms2000000094539848, createdTime=Sat Aug 02 10:07:46 CST 2025, time=2025-08-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=804128, encodeId=c2f9804128b3, content=审稿速度:1.0 | 投稿命中率:100.0<br>偏重的研究方向:神经生物学;细胞生物学;分子生物学<br>经验分享:赶着毕业拿学位,投稿BBRC,非常给力!7月19日晚上提交,立刻分配了稿件号并with editor,7月21日下午稿件退回要求补充上传WB的original images,当天补充完提交,提交后1小时就under review,今天7月23日中午接收,从初次提交到接收用时4天,十分效率!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=57, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba294682334, createdName=17142086d7m, createdTime=Thu Jul 23 15:29:56 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2264200, encodeId=6f932264200dd, content=请问那个short com有啥区别嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f6d6404751, createdName=ms5000000138196922, createdTime=Fri May 09 14:53:58 CST 2025, time=2025-05-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志现在是真的慢,投稿10天了是一点反馈都没有!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=663, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2259388, encodeId=c0432259388fb, content=short communication4.2号投稿,杂志会进行文字和图片查重。第二天就能知道查重结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a12f5512507, createdName=安徽, createdTime=Mon Apr 07 07:13:50 CST 2025, time=2025-04-07, status=1, ipAttribution=江苏省)]
    2025-04-07 安徽 来自江苏省

    short communication4.2号投稿,杂志会进行文字和图片查重。第二天就能知道查重结果

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分